Publications by authors named "A Curti"

Claim this Profile
C
CRISPR-Cas9 in acute myeloid leukaemia: Current state-of-art and future perspectives.
Federico Zingarelli, Jacopo Nanni, Gianluca Cristiano, Letizia Zannoni, Antonio Curti

Curr Opin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Davide Lazzarotto, Anna Maria Testi, Matteo Fanin, Federico Mosna, Sabina Chiaretti, Antonio Curti

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study.
M Delia, D Lazzarotto, S Imbergamo, F Mosna, C Papayannidis, A Curti

Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort.
Jorge Cortes, Antonio Curti, Pierre Fenaux, Brian A Jonas, Jürgen Krauter

J Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunotherapy landscape in AML: Defining knowledge gaps toward rational combinatorial strategies.
Marion Subklewe, Sergio Rutella, Antonio Curti

Semin Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis